6533b85bfe1ef96bd12ba152

RESEARCH PRODUCT

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research

Bernhard LämmleHeidi Rossmann

subject

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Letter to the Editors-in-ChiefHematologyAbnormal distributionVirologyVon Willebrand factor multimersADAMTS13Thrombosis ResearchMedicineIn patientbusinesshttps://doi.org/10.1016/j.thromres.2021.02.030